Research Summary
Low molecular weight heparin (LMWH) is a class of anticoagulant medications that are derived from unfractionated heparin, a natural substance found in the body. LMWH has a lower molecular weight and is produced through a process of enzymatic or chemical depolymerization of heparin. This modification results in a more predictable pharmacokinetic profile, improved bioavailability, and greater convenience in dosing compared to unfractionated heparin. LMWH works by inhibiting the activity of clotting factors and preventing the formation of blood clots, thereby reducing the risk of thrombosis and embolism. It is primarily used for the prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and in certain cases of unstable angina or myocardial infarction. LMWH is administered via subcutaneous injection and has a longer duration of action compared to unfractionated heparin, allowing for once or twice-daily dosing regimens. It is widely used in clinical practice due to its efficacy, ease of use, and lower risk of certain complications associated with unfractionated heparin, such as heparin-induced thrombocytopenia.
According to DIResearch's in-depth investigation and research, the global Low Molecular Weight Heparin market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Low Molecular Weight Heparin include Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Yantai Dongcheng Pharmaceutical Group, Techdow etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Low Molecular Weight Heparin. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Low Molecular Weight Heparin market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Low Molecular Weight Heparin market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Low Molecular Weight Heparin industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Low Molecular Weight Heparin Include:
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Yantai Dongcheng Pharmaceutical Group
Techdow
Low Molecular Weight Heparin Product Segment Include:
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine
Low Molecular Weight Heparin Product Application Include:
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Low Molecular Weight Heparin Industry PESTEL Analysis
Chapter 3: Global Low Molecular Weight Heparin Industry Porter's Five Forces Analysis
Chapter 4: Global Low Molecular Weight Heparin Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Low Molecular Weight Heparin Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Low Molecular Weight Heparin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Low Molecular Weight Heparin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Low Molecular Weight Heparin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Low Molecular Weight Heparin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Low Molecular Weight Heparin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Low Molecular Weight Heparin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Low Molecular Weight Heparin Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Low Molecular Weight Heparin Market Overview 1.1 Product Definition and Statistical Scope 1.2 Low Molecular Weight Heparin Product by Type 1.2.1 Global Low Molecular Weight Heparin Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Enoxaparin 1.2.3 Dalteparin 1.2.4 Tinzaparin 1.2.5 Fraxiparine 1.3 Low Molecular Weight Heparin Product by Application 1.3.1 Global Low Molecular Weight Heparin Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Treatment of Venous Thromboembolism 1.3.3 Complications of Pregnancy 1.3.4 Cardioversion of Atrial Fibrillation/Flutter 1.3.5 Others 1.4 Global Low Molecular Weight Heparin Market Revenue and Sales Analysis 1.4.1 Global Low Molecular Weight Heparin Market Size Analysis (2019-2030) 1.4.2 Global Low Molecular Weight Heparin Market Sales Analysis (2019-2030) 1.4.3 Global Low Molecular Weight Heparin Market Sales Price Trend Analysis (2019-2030) 1.5 Low Molecular Weight Heparin Market Development Status and Trends 1.5.1 Low Molecular Weight Heparin Industry Development Status Analysis 1.5.2 Low Molecular Weight Heparin Industry Development Trends Analysis 2 Low Molecular Weight Heparin Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Low Molecular Weight Heparin Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Low Molecular Weight Heparin Market Analysis by Regions 4.1 Low Molecular Weight Heparin Overall Market: 2023 VS 2024 VS 2030 4.2 Global Low Molecular Weight Heparin Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Low Molecular Weight Heparin Revenue and Market Share by Region (2019-2024) 4.2.2 Global Low Molecular Weight Heparin Revenue Forecast by Region (2025-2030) 4.3 Global Low Molecular Weight Heparin Sales and Forecast Analysis (2019-2030) 4.3.1 Global Low Molecular Weight Heparin Sales and Market Share by Region (2019-2024) 4.3.2 Global Low Molecular Weight Heparin Sales Forecast by Region (2025-2030) 4.4 Global Low Molecular Weight Heparin Sales Price Trend Analysis (2019-2030) 5 Global Low Molecular Weight Heparin Market Size by Type and Application 5.1 Global Low Molecular Weight Heparin Market Size by Type 5.1.1 Global Low Molecular Weight Heparin Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Low Molecular Weight Heparin Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Low Molecular Weight Heparin Market Size by Application 5.2.1 Global Low Molecular Weight Heparin Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Low Molecular Weight Heparin Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Low Molecular Weight Heparin Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Low Molecular Weight Heparin Market Size by Type 6.3.1 North America Low Molecular Weight Heparin Sales by Type (2019-2030) 6.3.2 North America Low Molecular Weight Heparin Revenue by Type (2019-2030) 6.4 North America Low Molecular Weight Heparin Market Size by Application 6.4.1 North America Low Molecular Weight Heparin Sales by Application (2019-2030) 6.4.2 North America Low Molecular Weight Heparin Revenue by Application (2019-2030) 6.5 North America Low Molecular Weight Heparin Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Low Molecular Weight Heparin Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Low Molecular Weight Heparin Market Size by Type 7.3.1 Europe Low Molecular Weight Heparin Sales by Type (2019-2030) 7.3.2 Europe Low Molecular Weight Heparin Revenue by Type (2019-2030) 7.4 Europe Low Molecular Weight Heparin Market Size by Application 7.4.1 Europe Low Molecular Weight Heparin Sales by Application (2019-2030) 7.4.2 ? Europe Low Molecular Weight Heparin Revenue by Application (2019-2030) 7.5 Europe Low Molecular Weight Heparin Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Low Molecular Weight Heparin Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Low Molecular Weight Heparin Market Size by Type 8.3.1 China Low Molecular Weight Heparin Sales by Type (2019-2030) 8.3.2 China Low Molecular Weight Heparin Revenue by Type (2019-2030) 8.4 China Low Molecular Weight Heparin Market Size by Application 8.4.1 China Low Molecular Weight Heparin Sales by Application (2019-2030) 8.4.2 China Low Molecular Weight Heparin Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Low Molecular Weight Heparin Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Low Molecular Weight Heparin Market Size by Type 9.3.1 APAC (excl. China) Low Molecular Weight Heparin Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Low Molecular Weight Heparin Revenue by Type (2019-2030) 9.4 APAC (excl. China) Low Molecular Weight Heparin Market Size by Application 9.4.1 APAC (excl. China) Low Molecular Weight Heparin Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Low Molecular Weight Heparin Revenue by Application (2019-2030) 9.5 APAC (excl. China) Low Molecular Weight Heparin Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Low Molecular Weight Heparin Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Low Molecular Weight Heparin Market Size by Type 10.3.1 Latin America Low Molecular Weight Heparin Sales by Type (2019-2030) 10.3.2 Latin America Low Molecular Weight Heparin Revenue by Type (2019-2030) 10.4 Latin America Low Molecular Weight Heparin Market Size by Application 10.4.1 Latin America Low Molecular Weight Heparin Sales by Application (2019-2030) 10.4.2 Latin America Low Molecular Weight Heparin Revenue by Application (2019-2030) 10.5 Latin America Low Molecular Weight Heparin Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Low Molecular Weight Heparin Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Low Molecular Weight Heparin Market Size by Type 11.3.1 Middle East & Africa Low Molecular Weight Heparin Sales by Type (2019-2030) 11.3.2 Middle East & Africa Low Molecular Weight Heparin Revenue by Type (2019-2030) 11.4 Middle East & Africa Low Molecular Weight Heparin Market Size by Application 11.4.1 Middle East & Africa Low Molecular Weight Heparin Sales by Application (2019-2030) 11.4.2 Middle East & Africa Low Molecular Weight Heparin Revenue by Application (2019-2030) 11.5 Middle East & Africa Low Molecular Weight Heparin Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Low Molecular Weight Heparin Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Low Molecular Weight Heparin Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Low Molecular Weight Heparin Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Low Molecular Weight Heparin Average Sales Price by Manufacturers (2020-2024) 12.2 Low Molecular Weight Heparin Competitive Landscape Analysis and Market Dynamic 12.2.1 Low Molecular Weight Heparin Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Aspen 13.1.1 Aspen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Aspen Low Molecular Weight Heparin Product Portfolio 13.1.3 Aspen Low Molecular Weight Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 Sanofi-aventis 13.2.1 Sanofi-aventis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Sanofi-aventis Low Molecular Weight Heparin Product Portfolio 13.2.3 Sanofi-aventis Low Molecular Weight Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 Pfizer 13.3.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Pfizer Low Molecular Weight Heparin Product Portfolio 13.3.3 Pfizer Low Molecular Weight Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 Opocrin 13.4.1 Opocrin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Opocrin Low Molecular Weight Heparin Product Portfolio 13.4.3 Opocrin Low Molecular Weight Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 CSBIO 13.5.1 CSBIO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 CSBIO Low Molecular Weight Heparin Product Portfolio 13.5.3 CSBIO Low Molecular Weight Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.6 Dongying Tiandong Pharmaceutical 13.6.1 Dongying Tiandong Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Product Portfolio 13.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.7 Changzhou Qianhong Bio-pharma 13.7.1 Changzhou Qianhong Bio-pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Product Portfolio 13.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.8 Yantai Dongcheng Pharmaceutical Group 13.8.1 Yantai Dongcheng Pharmaceutical Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Product Portfolio 13.8.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.9 Techdow 13.9.1 Techdow Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Techdow Low Molecular Weight Heparin Product Portfolio 13.9.3 Techdow Low Molecular Weight Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Low Molecular Weight Heparin Industry Chain Analysis 14.2 Low Molecular Weight Heparin Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Low Molecular Weight Heparin Typical Downstream Customers 14.4 Low Molecular Weight Heparin Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support